Platinum dibromide complexes with 10-(aryl)phenoxarsines: synthesis, structure, luminescent and biological properties
- Authors: Galimova M.F.1, Kondrashova S.A.1, Latypov S.K.1, Dobrynin A.B.1, Kolesnikov I.E.2, Lyubina A.P.1, Voloshina A.D.1, Musina E.I.1, Karasik A.A.1
-
Affiliations:
- Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
- St. Petersburg State University
- Issue: Vol 51, No 2 (2025)
- Pages: 75-88
- Section: Articles
- URL: https://journals.rcsi.science/0132-344X/article/view/288790
- DOI: https://doi.org/10.31857/S0132344X25020014
- EDN: https://elibrary.ru/MEMZBE
- ID: 288790
Cite item
Abstract
The reactions of 10-(aryl)phenoxarsines (L1 = 10-(4-tolyl)phenoxarsine, L2 is 10-(4-fluorophenyl) phenoxarsine, L3 is 10-(3-fluorophenyl)phenoxarsine, and L4 is 10-(2-methoxyphenyl)phenoxarsine) with Pt(COD)Br2 afford platinum(II) complexes [Pt(L1–4)2Br2] (I–IV). The complexes are characterized by elemental analysis, IR spectroscopy, mass spectrometry, and NMR (1Н, 13С, 195Pt) spectroscopy. The Pt(II) complexes in solutions exist as two isomers mutually exchanging at a rate intermediate in the NMR time scale. The molecular structures of complexes cis-II · chloroform, trans-II, and cis-IV · dichloromethane are determined by XRD (CIF files CCDC nos. 2368769 (cis-II · chloroform), 2368770 (trans-II), and 2368771 (cis-IV · chloroform)). The platinum(II) dibromide complexes can crystallize as both cis and trans isomers. The study of the photophysical properties of the platinum(II) complexes shows that the trans isomers are characterized by emission in the orange spectral range, whereas the cis isomers almost does not luminesce. 10-(Aryl)phenoxarsines and their platinum(II) complexes are tested to cytotoxicity against the M-HeLa and HuTu 80 human cancer cell lines and hepatocyte-like cells of the Сhang liver line.
About the authors
M. F. Galimova
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Author for correspondence.
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanS. A. Kondrashova
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanSh. K. Latypov
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanA. B. Dobrynin
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanI. E. Kolesnikov
St. Petersburg State University
Email: milya1949@mail.ru
Center for Optical and Laser Materials Research
Russian Federation, St. PetersburgA. P. Lyubina
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanA. D. Voloshina
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanE. I. Musina
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanA. A. Karasik
Federal Research Center “Kazan Scientific Center of Russian Academy of Sciences”
Email: milya1949@mail.ru
Arbuzov Institute of Organic and Physical Chemistry
Russian Federation, KazanReferences
- Williams J.A.G., Develay S., Rochester D.L. et al. // Coord. Chem. Rev. 2008. V. 252. P. 2596.
- Qi L., Luo Q., Zhang Y. et al. // Chem. Res. Toxicol. 2019. V. 32. P.1469.
- Galanski M.S., Keppler B.K. // Anticancer Agents Med. Chem. 2007. V. 7. P. 55.
- Kostova I. // Recent Patents Anticancer Drug Discov. 2006. V. 1. P.1.
- Yamaguchi Y., Ding W., Sanderson C.T. et al. // Coord. Chem. Rev. 2007. V. 251. P. 515.
- Wong K.M.-C., Yam V.W.-W. // Coord. Chem. Rev. 2007. V. 251. P. 2477.
- Augustyn K.E., Stemp E.D.A., Barton J.K. // Inorg. Chem. 2007. V. 46. P. 9337.
- Forrest S.R., Thompson M.E. // Chem. Rev. 2007. V. 107. P. 923.
- Zhao Q., Li F., Huang C. // Chem. Soc. Rev. 2010. V. 39. P. 3007.
- Zhao J., Ji S., Wu W. et al. // RSC Adv. 2012. V. 2. P. 1712.
- Mauro M., Aliprandi A., Septiadi D. et al. // Chem. Soc. Rev. 2014. V. 43. P. 4144.
- Garner K.L., Parkes L.F., Piper J.D. et al. // Inorg. Chem. 2010. V. 49. P. 476.
- Pittkowski R., Strassner T. // Beilstein J. Org. Chem. 2018. V. 14. P. 664.
- Kirlikovali K.O., Axtell J.C., Anderson K. et al. // Organometallics. 2018. V. 37. P. 3122.
- Brooks J., Babayan Y., Lamansky S. et al. // Inorg. Chem. 2002. V. 41. P. 3055.
- Shou R.-E., Chai W.-X., Song L. et al. // J. Cluster Sci. 2017. V. 28. P. 2185.
- Tseng C.-H., Fox M.A., Liao J.-L. et al. // J. Mater. Chem. C. 2017. V. 5. P. 1420.
- Yam V.W.-W., Law A.S.-Y. // Coord. Chem. Rev. 2020. V. 414. P. 213.
- Cebrián C., Mauro M. // Beilstein J. Org. Chem. 2018. V. 14. P. 1459.
- Yam V.W.-W., Chan K.H.-Y., Wong K.M.-C. et al. // Angew. Chem. Int. Ed. 2006. V. 45. P. 6169.
- Zhang Z.-H., Liu J., Wan L.-Q. et al. // Dalton Trans. 2015. V. 44. P. 7785.
- Williams J.A.G., Beeby A., Davies E.S. et al. // Inorg. Chem. 2003. V. 42. P. 8609.
- Hebenbrock M., González-Abradelo D., Strassert C.A. et al. // Z. Anorg. Allg. Chem. 2008. V. 644. P. 671.
- Imoto H., Tanaka S., Kato N. et al. // Organometallics. 2016. V. 35. P. 364.
- Galimova M.F., Begaliev T.A., Zueva E.M. et al. // Inorg. Chem. 2021. V. 60. № 9. P. 6804.
- Lachachi M.B., Benabdallah T., Aguiar P.M. et al. // Dalton Trans. 2015. V. 44. P. 11919.
- Гаврилов В.И., Гаврилова Г.Р., Хлебников В.Н. и др. // Изв. вузов. Сер. Химия и хим. технология. 1973. T. 12. № 10. C. 1602.
- Adamo C., Barone V. // J. Chem. Phys. 1999. V. 110. P. 6158.
- Dolg M., Wedig U., Stoll, H. et al. // J. Chem. Phys. 1987. V. 86. P. 866.
- Frisch M.J., Trucks G.W., Schlegel H.B. et al. Gaussian 03. Revision B.04. Pittsburgh (PA): Gaussian Inc., 2003
- Sheldrick G.M. SADABS. Program for Empirical X-ray Absorption Correction. Bruker-Nonius, 1990–2004.
- Altomare A., Cascarano G., Giacovazzo C. et al. // Acta Crystallogr. A. 1991. V. 47. P. 744.
- Sheldrick G. SHELX-97: Programs for Сrystal Structure Analysis. Göttingen (Germany): Göttingen University, 1997.
- Farrugia L.J. // J. Appl. Crystallogr. 1999. V. 32. P. 837.
- APEX2 (version 2.1). SAINTPlus. Data Reduction and Correction Program (version 7.31A). Madison (WI, USA): Bruker Advansed X-ray Solutions, BrukerAXS Inc., 2006.
- Voloshina A.D., Semenov V.E., Strobykina A.S. et al. // Russ. J. Bioorg. 2017. V. 43. P. 170.
- Dub P.A., Filippov O.A., Belkova N.V. et al. // J. Phys.Chem. A. 2009. V. 113. P. 6348.
- Moldovan N., Lönnecke P., Silaghi-Dumitrescu I. et al. // Inorg. Chem. 2008. V. 47. P. 1524.
- Imoto H., Sasaki H., Tanaka S. et al. // Organometallics. 2017. V. 36. P. 2605.
- Galimova M.F., Burdina K.A., Dobrynin A.B. et al. // Inorg. Chim. Acta. 2024. V. 563. P. 121896.
Supplementary files
